Skip to main content
. 2010 May 17;10:10. doi: 10.1186/1472-6823-10-10

Table 1.

Effects of first-line therapy with bromocriptine, pergolide or cabergoline on tumor size and prolactin levels in patients with macroprolactinomas [7-9]

Bromocriptine (n = 27) Pergolide (n = 22) Cabergoline (n = 26)
Baseline prolactin (μg/L) 2260 2938 1013
Normalized prolactin (% of patients) 66 68 100
≥50% tumor reduction (% of patients) 64 86 96
Duration of treatment (months) 12 27 24